Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Cooper

Showing results (41-50 of 399) with videos related to

Pageof 40
Sort By:
Circulation Research|December 15, 2010
Epigenetics: mechanisms and implications for diabetic complicationsMark E Cooper, Assam El-Osta
Blood|September 23, 2017
Diabetic kidney disease: as easy as aPC?James D McFadyen, Mark E Cooper
Current Opinion in Nephrology and Hypertension|February 22, 2002
Hypertension and diabetesKarin Jandeleit-Dahm, Mark E Cooper
Diabetes & Vascular Disease Research|January 28, 2017
Hypoglycaemia in patients with diabetes mellitus and renal impairmentThushan S Hettige, Mark E Cooper
Diabetes & Vascular Disease Research|April 7, 2010
Arterial hypertension defeated? Attacked from another angleDrazenka Pongrac Barlovic, Mark E Cooper
Presse Medicale (Paris, France : 1983)|October 2, 2023
Clinical trials with reno-vascular end points in patients with diabetes: Changing the scenario over the past 20 yearsTomasz J Block, Mark E Cooper
Kidney International|June 18, 2026
Resolving the VEGF paradox in DKD: VEGFR1 blockade shows promising renoprotectionJakob A Østergaard, Mark E Cooper
Diabetes Technology & Therapeutics|August 8, 2002
Combination antihypertensive therapy in the treatment of diabetic nephropathyGeoffrey Boner, Zemin Cao, Mark E Cooper
Current Hypertension Reports|February 3, 2012
What are new avenues for renal protection, in addition to RAAS inhibition?Shinji Hagiwara, Phillip Kantharidis, Mark E Cooper
Idrugs : the Investigational Drugs Journal|November 25, 2004
Treatment for diabetic nephropathy - a review of the recent patent literatureRiccardo Candido, Bruno Fabris, Mark E Cooper
Pageof 40

Showing results (41-50 of 399) with videos related to

Sort By:
Pageof 40
Circulation Research|December 15, 2010
Epigenetics: mechanisms and implications for diabetic complicationsMark E Cooper, Assam El-Osta
Blood|September 23, 2017
Diabetic kidney disease: as easy as aPC?James D McFadyen, Mark E Cooper
Current Opinion in Nephrology and Hypertension|February 22, 2002
Hypertension and diabetesKarin Jandeleit-Dahm, Mark E Cooper
Diabetes & Vascular Disease Research|January 28, 2017
Hypoglycaemia in patients with diabetes mellitus and renal impairmentThushan S Hettige, Mark E Cooper
Diabetes & Vascular Disease Research|April 7, 2010
Arterial hypertension defeated? Attacked from another angleDrazenka Pongrac Barlovic, Mark E Cooper
Presse Medicale (Paris, France : 1983)|October 2, 2023
Clinical trials with reno-vascular end points in patients with diabetes: Changing the scenario over the past 20 yearsTomasz J Block, Mark E Cooper
Kidney International|June 18, 2026
Resolving the VEGF paradox in DKD: VEGFR1 blockade shows promising renoprotectionJakob A Østergaard, Mark E Cooper
Diabetes Technology & Therapeutics|August 8, 2002
Combination antihypertensive therapy in the treatment of diabetic nephropathyGeoffrey Boner, Zemin Cao, Mark E Cooper
Current Hypertension Reports|February 3, 2012
What are new avenues for renal protection, in addition to RAAS inhibition?Shinji Hagiwara, Phillip Kantharidis, Mark E Cooper
Idrugs : the Investigational Drugs Journal|November 25, 2004
Treatment for diabetic nephropathy - a review of the recent patent literatureRiccardo Candido, Bruno Fabris, Mark E Cooper
Pageof 40